학술논문

Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin
Document Type
Article
Source
In Journal of Thoracic Oncology November 2009 4(11):1397-1403
Subject
Language
ISSN
1556-0864